Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Clinical trial NCT07172958 · RECRUITING

Trial details

NCT number: NCT07172958
Sponsor: Children's National Research Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Rhabdomyosarcoma Ewing Sarcoma Neuroblastoma Wilms Tumor

Start date: 2026-01-27
Primary completion: 2041-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.